About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Women Surviving Ovarian Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00596349

Women Surviving Ovarian Cancer

The purpose of this study is to help us learn more about how women who have had or now have ovarian cancer are doing 5 years or more from their diagnosis. We want to learn about general quality of lif...

Lead sponsor: Memorial Sloan Kettering Cancer Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

Queens Cancer Center of Queens Hospital

Age

All ages

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Women with invasive epithelial ovarian cancer who are disease-free and 5 to 10 years from diagnosis (for Cohort A) and have never experienced a recurrence of epithelial ovarian cancer
•Women with epithelial ovarian cancer who have had one or more relapses, but are clinically currently disease-free, 5- to 10 years from diagnosis (for Cohort B)
•Women with current evidence of epithelial ovarian cancer who are alive with disease 5 to 10 years from diagnosis (for Cohort C)
•Fluency in English
•Written informed consent

Exclusion Criteria

•Inability to read, communicate in English
•ovarian cancer of low malignant potential (borderline tumors)

Related studies

RECRUITINGPhase 2

Lysergic Acid Diethylamide (LSD) in Palliative Care

NCT05883540 · Palliative Care, Pain, and more

Male Experiences With Intra Cytoplasmic Sperm Injection (ICSI) and Reduced Sperm Quality

NCT07546435 · Psychological Experience in Fertility Treatment, Hypogonadism, and more

RECRUITINGPhase 3

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

NCT06915025 · Epithelial Ovarian Cancer, Ovarian Cancer, and more

intErnet-based iNterventions FOR Cardiac arrEst suRvivors

NCT06395558 · Cognitive Impairment, Depression, Anxiety, and more

RECRUITINGPhase 1/2

[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

NCT07432633 · Colorectal Cancer, Epithelial Ovarian Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 26, 2009Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment62

Start dateNov 2004

Last updatedFeb 26, 2009

Condition

Epithelial Ovarian Cancer Quality of Life Survivorship

Locations shown

Memorial Sloan Kettering Cancer Center

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 26, 2009Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions